News & Events


Journal of Managed Care and Specialty Pharmacy
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
Journal of the American Medical Association
Cost-effectiveness thresholds used by study authors, 1990-2021
Value in Health
Developing Criteria for Health Economic Quality Evaluation Tool
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans
Health Policy OPEN
The impact of external reference pricing on pharmaceutical costs and market dynamics
Journal of Managed Care + Specialty Pharmacy
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
STAT News First Opinion
The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy
Journal of Managed Care + Specialty Pharmacy
Commercial health plans use of patient subgroup restrictions: An analysis of orphan and FDA-expedited programs
Alzheimer's & Dementia
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease